Technology, Healthcare Jun 24, 2022 10:59 AM (GMT+8) · EqualOcean
On June 23, the enterprise of tumor gene detection and early screening for cancer and Swiss gene announced the launch of "quansining", a multi cancer early screening product. Based on the development of hifi technology system originally developed by Swiss gene, it screened six high-risk and high-risk cancers in China, including lung cancer, esophageal cancer, gastric cancer, liver cancer, pancreatic cancer and colorectal cancer. According to the disclosure of Swiss gene, the sensitivity of the product was 87.58%, the specificity was 99.09% and the traceability accuracy was 82%.

This text is a result of machine translation.